Conmed expects to use revolver to finance Bionx acquisition

By Sara Rosenberg

New York, Jan. 13 - Conmed Corp. anticipates borrowing under its $100 million revolver to help finance the approximately $48 million acquisition of Bionx Implants Inc. The merger is expected to be completed within the next four months.

Completion of the merger is subject to certain conditions including Bionx shareholder approval, according to a news release.

Conmed is a Utica, N.Y. medical technology company specializing in instruments, implants and video equipment for arthroscopic sports medicine and powered surgical instruments for orthopedic, ENT, neurosurgery and other surgical specialties.

Central Garden & Pet to bring $150 million notes

By Paul A. Harris

St. Louis, Jan. 13 - Central Garden & Pet Co. announced in a press release Monday that it would bring $150 million of senior subordinated notes due 2013.

Proceeds from the Rule 144A deal will be used to redeem its outstanding convertible notes including the payment of premium and accrued interest, and to reduce a portion of the outstanding indebtedness under its senior credit facilities.

No timing or underwriters were disclosed in the release.

The issuer is a marketer and producer of products for the pet and lawn and garden supplies markets, and is headquartered in Lafayette, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.